Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited has released its Corporate Governance Statement, affirming its commitment to good corporate governance in line with the Australian Securities Exchange (ASX) guidelines. The statement outlines the company’s adherence to ASX Corporate Governance Principles and Recommendations, emphasizing the clear distinction of roles between the Board and senior executives, and the Board’s ultimate authority over management. This governance framework aims to enhance the company’s strategic implementation and performance oversight, benefiting all stakeholders.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.15 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection prevention solutions. The company is known for its innovative products and services that focus on reducing the risk of infection transmission in healthcare settings.
YTD Price Performance: 34.55%
Average Trading Volume: 725,502
Technical Sentiment Signal: Buy
Current Market Cap: A$1.23B
See more data about NAN stock on TipRanks’ Stock Analysis page.